Our products create the future

Current customer information

No decision has yet been made by the EU Commission on the applications for authorisation made by the CTACsub Consortium for the continued use of chromium trioxide.

However, Article 58(1)(c)(ii) of the REACH Regulation stipulates that those downstream users who are directly or indirectly supplied by the applicants will see their operations (where covered by the applications) extended beyond the expiry date until a decision has been made by the Commission.

 We confirm that Dr. Hesse is a member of the CTAC consortium and was actively involved in the preparation of the applications for authorisation of chromium trioxide.

Dr. Hesse purchases chromium trioxide solely from the supply chain of the CTACsub applicants.

The processes involving chromium trioxide supplied by Dr. Hesse are covered by the applications made by the CTACsub consortium.

May 2019